Aplagon Oy
Business Services · Finland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Tukholmankatu 2a 8 A, Helsinki, Uusimaa,...Phone Number
+358 407625159Website
www.aplagon.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Aplagon Oy
About Aplagon Oy (www.aplagon.com) Aplagon Oy is a pharmaceutical discovery and development company, based in Helsinki, Finland, developing proprietary locally acting antithrombotic products (APACs) for the management of vascular intervention-related blood vessel occlusions. The Company has a strong network of collaborators among top scientists and laboratories in Europe and the US in the field of vascular medicine. It is backed by leading Finnish life science investors: Innovestor Ventures; Jenny and Antti Wihuri Foundation; and Helsinki University Funds.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aplagon Oy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Aplagon Oy has new funding data
Click to see if Aplagon Oy had a recent Job posting/layoffs
Check if Aplagon Oy has recently received funding, and reach out quickly before it becomes old news!
Aplagon Oy, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Aplagon Oy
Check out if Aplagon Oy is spiking on competitors!
Product Launch: Get notified when Aplagon Oy launches new products
Earning: See what the market has to say on Aplagon Oy recently announced quarterly report
Recommended Actions
Find VP level buyers at Aplagon Oy
Find 2 more new buyers
Company Profile Activity
Activity Insights
Aplagon Oy is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aplagon Oy is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aplagon Oy.
Aplagon Oy financials insights
Gather financial insights about Aplagon Oy, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$7.1M
Aplagon Oy Tech Stack
A closer look at the technologies used by Aplagon Oy
See more technologies
Aplagon Oy News & Media
Aplagon Announces Review Publication on APAC, a First-in-Class Dual-Action Antithrombotic to Treat Unmet Clinical Needs in Thromboinflammatory Diseases
HELSINKI, June 01, 2026 (GLOBE NEWSWIRE) -- Aplagon, a clinical-stage biotech developing first-in-class therapies for thromboinflammatory diseases, today announced the comprehensive publication of an invited review article in Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia
HELSINKI, March 12, 2026 (GLOBE NEWSWIRE) -- Aplagon, a clinical stage biotech pioneering a first-in-class treatment for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and anticoagulant effects, announced today the first patient has been dosed in its Phase 2a ‘HEALING’ clinical trial in peripheral arterial occlusive disease (PAOD) leading to chronic limb threatening ischemia (CLTI).Aplagon Announces EUR 7 Million Financing to Advance its APAC Therapeutic for Thrombo-Inflammatory Diseases into Phase 2A Clinical Trials
Financing led by new Investors Fåhraeus Startup and Growth and EIC Fund Financing led by new Investors Fåhraeus Startup and Growth and EIC Fund
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Aplagon Oy
Sign Up For FreeTo access detailed company insights
About Aplagon Oy (www.aplagon.com) Aplagon Oy is a pharmaceutical discovery and development company, based in Helsinki, Finland, developing proprietary locally acting antithrombotic products (APACs) for the management of vascular intervention-related blood vessel occlusions. The Company has a strong network of collaborators among top scientists and... Read More
